Emerging Innovations in Vincristine-Encapsulated Nanoparticles: Pioneering a New Era in Oncological Therapeutics Publisher



Bakhshi S¹ ; Shoari A² ; Alibolandi P³ ; Ganji M⁴ ; Ghazy E⁵ ; Rahdar A⁶ ; Fathikarkan S^{7, 8} ; Pandey S^{9, 10} Show Affiliations
Source: Journal of Drug Delivery Science and Technology Published:2024

Abstract

This encompassing review article synthesizes multiple studies and methods all revolving around the innovative use of nanoparticles (NPs) for Vincristine (VCR) delivery as a cancer treatment. The study presents a broad range of applications derived from several studies, such as NP delivery systems that trigger apoptosis, targeted drug delivery strategies for Ewing's sarcoma, therapy for brain gliomas, and potential uses for non-small cell lung carcinoma (NSCLC). Several studies highlight promising results, such as the reduction of tumors, enhanced survival rates, and lower cell survival rate in cancer cells. Moreover, diverse NPs' formulations each presenting varied encapsulation efficiencies and zeta potentials, yet maintaining a consistently small size are illustrated, reinforcing the versatility of NP utilization in this field. This paper overall provides a compelling overview of state-of-art NP usage in cancer therapeutics, serving as a foundation for further exploration and improved treatment strategies to combat diverse cancer types effectively. © 2023 Elsevier B.V.